PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50121F33010Procure a influenza a(h2nx) VIRUS vaccine — Seqirus Inc

Seqirus Inc holds $419.6M across 33 federal awards, concentrated at Department of Health and Human Services (HHS). Competition previously drew 2 offers. Recompete timing centers on the Jan 31, 2027 PoP end — agencies typically plan 12–18 months ahead.

Barda - Aspr / Daappo / Barda Dcma

Awarding office

Seqirus Inc

Recipient

Jan 31, 2027

PoP end

$21.4M

Obligated

541714

NAICS

AN14

PSC

2 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Seqirus Inc — $90

Contract facts

Federal

Contract number75A50121F33010

Also listed as75A50118D00004-75A50121F33010

AgencyBarda - Aspr / Daappo / Barda Dcma

Awarding officeBarda - Aspr / Daappo / Barda Dcma

IncumbentSeqirus Inc

UEIZ6N1LJ2RD6E3

NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN14

Parent IDIQ / IDV75A50118D00004

Place of performanceHOLLY SPRINGS, NC

PoP end (current)Jan 31, 2027

Obligated$21.4M

THE PURPOSE OF THIS TASK ORDER IS TO PROCURE A INFLUENZA A(H2NX) VIRUS VACCINE CANDIDATE(S) AND CONDUCT CLINICAL TRIAL is a federal award for Barda - Aspr / Daappo / Barda Dcma held by Seqirus Inc. Estimated value $35M ($21.4M obligated). Current period of performance ends Jan 31, 2027. Last award drew 2 bidders. Place of performance: HOLLY SPRINGS, NC.

THE PURPOSE OF THIS TASK ORDER IS TO PROCURE A INFLUENZA A(H2NX) VIRUS VACCINE CANDIDATE(S) AND CONDUCT CLINICAL TRIAL

Recompete timing

Public

● Expiring in 163 days

Current PoP ends Jan 31, 2027 (163 days remaining). Agencies typically plan 12–18 months ahead — at 5.4 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Seqirus Inc — $419.6M obligated across 33 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$419.6M · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75A50121F33010?

75A50121F33010 (Procure a influenza a(h2nx) VIRUS vaccine) is a Barda - Aspr / Daappo / Barda Dcma award with an estimated value of $35M, currently held by Seqirus Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75A50121F33010?

Barda - Aspr / Daappo / Barda Dcma awarded 75A50121F33010 to Seqirus Inc.

Who is the incumbent on 75A50121F33010?

Seqirus Inc is the incumbent with $419.6M across 33 related awards in SCOUT’s public footprint. The current period of performance ends Jan 31, 2027.

When does Seqirus Inc’s 75A50121F33010 come up for recompete?

SCOUT tracks a period-of-performance end of Jan 31, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 20, 2026 · refreshed monthlyLatest procurement action Oct 9, 2025